Ioannis Psallidas

9PUBLICATIONS
12CO-AUTHORS
Respiratory diseasesPharmaceutical delivery technologiesPredictive and prognostic markersPsychosocial aspects of childbirth and perinatal mental healthCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 20, 2026
Phase III LUNA clinical programme: design of four randomised, double-blind, placebo-controlled studies assessing the efficacy and safety of tozorakimab in patients with symptomatic COPD and a high risk of exacerbations.

|Sep 10, 2020
Navafenterol (AZD8871) in healthy volunteers: safety, tolerability and pharmacokinetics of multiple ascending doses of this novel inhaled, long-acting, dual-pharmacology bronchodilator, in two phase I, randomised, single-blind, placebo-controlled studies.

Victor Balaguer, Muna Albayaty, Eulalia Jimenez

|Nov 02, 2019
Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients.

Nikolaos I Kanellakis, John M Wrightson, Rob Hallifax

|Aug 07, 2019
Osteopontin as a Link between Inflammation and Cancer: The Thorax in the Spotlight.

Anne-Sophie Lamort, Ioanna Giopanou, Ioannis Psallidas

|Mar 04, 2019
Palliative care in mesothelioma: Are current services RESPECT-able enough?

Neelam Kumar, Doraid Alrifai, Ioannis Psallidas

|Feb 16, 2019
A Randomized Trial of Dual-Acting Bronchodilator AZD8871 for Chronic Obstructive Pulmonary Disease.

Dave Singh, Rainard Fuhr, Lali Jimenez

Pageof 2

Frequent Collaborators

1 joint publications

Matthew Evison

1 joint publications

Kevin G Blyth

1 joint publications

Rahul Bhatnagar

1 joint publications

Dave Singh